| 000 | 01132 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513132858.0 | ||
| 264 | 0 | _c19980121 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0920-9964 | ||
| 024 | 7 |
_a10.1016/S0920-9964(97)00079-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoff, D C | |
| 245 | 0 | 0 |
_aGlutamate in schizophrenia: clinical and research implications. _h[electronic resource] |
| 260 |
_bSchizophrenia research _cOct 1997 |
||
| 300 |
_a157-68 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAging _xphysiology |
| 650 | 0 | 4 | _aCitric Acid Cycle |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aGlutamic Acid _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhencyclidine _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Amino Acid _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Glutamate _xphysiology |
| 650 | 0 | 4 |
_aSchizophrenia _xphysiopathology |
| 700 | 1 | _aWine, L | |
| 773 | 0 |
_tSchizophrenia research _gvol. 27 _gno. 2-3 _gp. 157-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0920-9964(97)00079-0 _zAvailable from publisher's website |
| 999 |
_c9386220 _d9386220 |
||